Anthropic sets IPO price at $83 and registers 178.25m more Class A shares
Anthropic, PBC filed a Form S-1MEF on 18 November under Rule 462(b), registering 178,250,000 additional shares of Class A common stock, including 23,250,000 shares subject to the underwriters' option. The filing's fee table calculates the registration fee from 'the initial public offering price of $83.00 per share.' The same filing says the prior registration statement was declared effective that day. A Nasdaq certification earlier on 18 November approved the Class A shares for listing upon official notice of issuance.
Update, 19 November: Since this article was first published, Anthropic’s EDGAR filing list has shown a Commission notice of effectiveness for the Form S-1 (form EFFECT, 9999999995-26-003574, accepted 05:15 London time on 19 November), which gives the effectiveness date as “November 18, 2026 10:00 A.M.”, and a final prospectus under Rule 424(b)(4) (0001628280-26-074944, accepted 11:05 London time on 19 November). The 424(b)(4) covers 980,000,000 shares of Class A common stock at an initial public offering price of $83.00; Anthropic is selling 956,351,354 of them and selling stockholders the other 23,648,646. Statements below that those documents were not on EDGAR describe the position as of the morning of 19 November.
Anthropic, PBC filed a Form S-1MEF on 18 November (accession 0001628280-26-074904, accepted at 6:42pm ET (11:42pm UK) that evening) to register additional shares of Class A common stock under Rule 462(b) of the Securities Act of 1933. EDGAR’s filing index lists the form under File No. 333-300148 and shows an effectiveness date of 18 November 2026. The form checks the Rule 462(b) box and names the earlier registration statement as File No. 333-299633. It states: “This Registration Statement shall become effective upon filing with the Securities and Exchange Commission in accordance with Rule 462(b) promulgated under the Securities Act.”
The explanatory note says the statement is being filed “with respect to the registration of 178,250,000 additional shares of Class A common stock (including 23,250,000 shares of Class A common stock subject to purchase upon exercise of the option to purchase additional shares granted to the underwriters)” of Anthropic, PBC, “to be sold by the Company”. The Filing Fee Table filed as Exhibit 107 records those 178,250,000 shares at a “Proposed Maximum Offering Price Per Unit” of $83.00 and a “Maximum Aggregate Offering Price” of $14,794,750,000.00. An offering note to the table says the registration fee is calculated “based on the number of shares being registered and the initial public offering price of $83.00 per share.”
The S-1MEF, filed on 18 November, also says the contents of the Registration Statement on Form S-1 (File No. 333-299633), initially filed on 26 October 2026 and “which was declared effective by the Commission on November 18, 2026,” including exhibits, are incorporated by reference. The fee table uses the same wording on the prior statement’s effectiveness. A standalone Commission notice of effectiveness (form EFFECT) was not on Anthropic’s EDGAR filing list, in EDGAR full-text search, or in the 18 November daily master index as of the morning of 19 November, and neither was a final prospectus on Form 424(b). The company’s submissions feed last showed a group of Form 3 filings accepted shortly after 9:00pm ET on 18 November (shortly after 2:00am UK on 19 November).
The size of the registered offering
Amendment No. 3 to the Form S-1, filed on 17 November and incorporated by the S-1MEF, is still marked “Subject to Completion. Dated November 17, 2026.” Its cover offers “825,000,000 Shares” of Class A common stock and says: “It is currently estimated that the initial public offering price per share will be between $70.00 and $78.00.” The $83.00 initial public offering price in the S-1MEF fee table is above that range.
The offering table in Amendment No. 3 lists 801,351,354 shares of Class A common stock offered by the company and 23,648,646 shares offered by selling stockholders, together 825,000,000 shares, plus an “Underwriters’ option to purchase additional shares of Class A common stock from us” of 123,750,000 shares. In the underwriting section, Anthropic said: “Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC are the representatives of the underwriters (‘representatives’).” It also said it would grant the underwriters “an option, exercisable for 30 days from the date of this prospectus, to purchase up to an additional 123,750,000 shares of Class A common stock at the initial public offering price set forth on the cover page of this prospectus, less underwriting discounts and commissions.”
The 23,250,000 option shares in the S-1MEF are additional to that 123,750,000-share option, not a replacement for it. The 178,250,000 additional shares registered on 18 November are all to be sold by the company. Of that increment, 155,000,000 shares are not described as option shares. If the offering is otherwise as described in Amendment No. 3, adding them to its 825,000,000 shares would give 980,000,000 shares in the firm offering. At the $83.00 initial public offering price stated in the fee table, those firm shares would represent $81.34 billion of gross proceeds, before underwriting discounts. Combining the two option tranches, 123,750,000 plus 23,250,000, would bring the underwriters’ option to 147,000,000 shares and the registered total, if the option were exercised in full, to 1,127,000,000 shares, or $93.541 billion at $83.00. Those combined totals are arithmetic from the two filings; a Form 424(b) stating a single official table of shares offered and gross proceeds was not on EDGAR as of the morning of 19 November.
The fee table says the company “previously registered securities at an aggregate offering price not to exceed $74,002,500,000 on the Prior Registration Statement,” and that, in accordance with Rule 462(b), “an additional amount of shares having a proposed maximum aggregate offering price of $14,794,750,000 is hereby registered, which includes shares issuable upon the exercise of the underwriters’ option to purchase additional shares.” The S-1MEF states that the additional shares “are in an amount and at a price that together represent no more than 20% of the maximum aggregate offering price set forth in the Filing Fee Table filed as Exhibit 107 to the Prior Registration Statement.”
Amendment No. 3 also describes a concurrent private placement. It says that, immediately subsequent to completion of the offering and subject to certain conditions, Google LLC, NVIDIA Corporation, Advanced Micro Devices, Inc., Broadcom Inc., Micron Technology, Inc., Microsoft Corporation, and TSMC Partners, Ltd. “will purchase, severally and not jointly, an aggregate of $26.0 billion of our Class N common stock from us in a private placement at a price per share equal to the initial public offering price.” Those Class N shares “will not be registered in this offering” and “will not be subject to market standoff agreements with us or lock-up agreements with the underwriters.” Share counts for that placement in Amendment No. 3 were illustrated at an assumed price of $74.00, the then midpoint of the $70.00 to $78.00 range, and are not restated here. The amendment also describes staged lock-up and market standoff restrictions measured from the date of the prospectus; without a dated final prospectus on EDGAR, those periods are not converted into calendar dates in this article.
Nasdaq listing and the IPO Halt Cross
Earlier on 18 November, at 9:12am ET (2:12pm UK), Nasdaq filed a certification letter with the Commission (accession 0001354457-26-001088). The letter, dated 18 November 2026 and signed by Eun Ah Choi, Senior Vice President, Global Head of Regulatory Operations, The Nasdaq Stock Market LLC, certifies that on 17 November 2026 the Exchange received a copy of Anthropic’s Form 8-A 12(b) for “Class A common stock, $0.00001 par value per share.” It says: “We further certify that the security described above has been approved by the Exchange for listing and registration upon official notice of issuance.” It also says Nasdaq understands that the registrant “is seeking effectiveness of the Form 8-A 12(b) concurrently with effectiveness of its 1933 Act Registration Statement,” and that Nasdaq joins in that request.
Amendment No. 3, filed on 17 November, says: “We have been approved to list our Class A common stock on the Nasdaq Global Select Market under the symbol ‘ANT.’” A first-trade date, a first-trade price, and a Nasdaq IPO calendar entry were not confirmed from a primary Nasdaq notice as of the morning of 19 November, and this article does not infer one.
Once an IPO security is listed on Nasdaq, initial pricing is not a conventional opening cross. Under Equity 4, Rule 4120(b)(1)(B)(iii), Nasdaq may halt trading “for a security that is the subject of an IPO on Nasdaq.” Rule 4120(b)(4)(C), “Resumption of Trading After an IPO Halt,” as set out in Exhibit 5 to SR-NASDAQ-2026-064 and designated operative on 10 August 2026, then governs the release. The rule provides for a 10-minute “Display Only Period” during which market participants may enter quotes and orders in Nasdaq systems. “In addition, beginning at 4:00 a.m., market participants may enter orders in a security that is the subject of an IPO on Nasdaq.” That 4:00 a.m. entry time is 9:00am UK on the same calendar day.
After the Display Only Period, the security enters a “Pre-Launch Period” of indeterminate duration. The Pre-Launch Period ends, and Nasdaq releases the security for trading, when three conditions are met. First, “Nasdaq receives notice from the underwriter of the IPO that the security is ready to trade.” The system then calculates the Current Reference Price at that time (the “Expected Price”) and displays it to the underwriter; if the underwriter approves proceeding, Nasdaq runs validation checks. Second, “The Nasdaq system must determine that all market orders will be executed in the cross.” Third, the security must pass a price validation test: the underwriter selects upper and lower price bands, the system compares the Expected Price with the actual price calculated by the cross, and if the difference exceeds the selected band the security is not released and the Pre-Launch Period continues. The available bands “shall include $0 but shall not be in excess of $0.50.”
The underwriter, with the concurrence of Nasdaq, “may determine at any point during the IPO Halt Cross process up through the conclusion of the Pre-Launch Period to postpone and reschedule the IPO.” Market participants may continue to enter orders and cancellations for the cross “up to the point that the cross auction process commences.” Rule 4120(b)(4)(C) refers to the cross process in Rule 4753, Nasdaq’s Halt Cross rule. None of that process sets, or predicts, the first printed trade at the $83.00 offering price.
The 16 ETFs already on file
A listing of Anthropic’s Class A shares is also the reference event for a group of exchange-traded funds that have already filed prospectuses linked to those shares. As The MidPoint News reported on 18 November, 16 funds from eight trusts had a Form 485BPOS prospectus on file in the EDGAR filings we checked, 14 of them with a 2x daily long or short objective. None of those funds had an exchange certification on EDGAR as of that check, two issuers had filed supplements saying their funds were not currently available, and three funds were left without a ticker in that article because the issuers’ filings did not settle one. Effectiveness of Anthropic’s registration statement and Nasdaq’s certification of the Class A shares do not, by themselves, list or launch those funds.
This article does not apply index fast-entry or reconstitution rules to ANT. Those tests belong to the index providers’ published methodologies, which are not cited here.
Why it matters
For a trading desk, the documents now on EDGAR fix an initial public offering price and enlarge the registered Class A deal, and they record that Nasdaq has approved the shares for listing upon official notice of issuance under the symbol ANT on the Nasdaq Global Select Market. They do not yet publish a final prospectus or a first-trade time. The print that will matter in the opening minutes is the IPO Halt Cross, which cannot run until the underwriters give Nasdaq notice that the security is ready to trade and the price-band and market-order checks in Rule 4120(b)(4)(C) are satisfied. Desks watching ANT will want that underwriter release, the Pre-Launch conditions in Rule 4120(b)(4)(C), and any later 424(b) or exchange notice, rather than treating $83.00 as a predicted first-trade price. The same listing is the underlying for the 16 funds already on file; those products remain a separate certification and availability question, as set out in our earlier report.
Sources
- Anthropic, PBC: Rule 424(b)(4) prospectus, SEC EDGAR, 19 Nov 2026 (0001628280-26-074944)
- SEC notice of effectiveness for Anthropic, PBC Form S-1, SEC EDGAR (9999999995-26-003574)
- Anthropic, PBC: Form S-1MEF, 18 November 2026 (File No. 333-300148; accession 0001628280-26-074904)
- Exhibit 107 Filing Fee Table to the S-1MEF (s1mef-exfilingfees3.htm)
- EDGAR filing index for the S-1MEF (accepted 18:42:01 ET; effectiveness date 18 November 2026)
- Nasdaq CERT letter dated 18 November 2026 (accession 0001354457-26-001088)
- Anthropic, PBC: Amendment No. 3 to Form S-1, 17 November 2026 (Registration No. 333-299633)
- Release No. 34-106139 (SR-NASDAQ-2026-064), 14 August 2026
- SR-NASDAQ-2026-064, Exhibit 5 (Rule 4120, including Rule 4120(b)(4)(C))
- The MidPoint News, 18 November 2026: Anthropic files to register its shares on Nasdaq; 16 ETFs referencing them have prospectuses on file
News and information only, not investment advice. See our disclaimer.
Spotted an error? Email corrections@themidpointnews.com. See our editorial standards, including how we use AI and handle corrections.




